InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Butler Thomas Andrew, Chief Executive Officer. Director active across 1 companies, notably Biomea Fusion, Inc.. In total, 4 reports have been published. Total volume traded: €5.6m. The latest transaction was filed on 23 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€269,80424,000 shares@ €11.24189.7% of flow
Common Stock
SEC:0001567619-21-016341·
Ideal exit: 20 May 2022 (T+270)
€269,80424,000 shares@ €11.24180.28% mcap4.9% of flow
Common Stock
SEC:0001567619-21-016341:0·
Ideal exit: 20 May 2022 (T+270)
€3m176,470 shares@ €14.200190.3% of flow
Common Stock
SEC:0001567619-21-016159·
Ideal exit: 10 Jan 2022 (T+270)
€3m176,470 shares@ €14.20012.57% mcap45.1% of flow
Common Stock
SEC:0001567619-21-016159:0·
Ideal exit: 10 Jan 2022 (T+270)
4 of 4 declarations
About Butler Thomas Andrew
Thomas Andrew Butler is the Chief Executive Officer of Biomea Fusion, Inc. He is responsible for the strategic and operational direction of the company. His role is essential in ensuring growth and innovation in the pharmaceutical sector.
